Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer

ABSTRACT: The objective is to compare the efficacy and safety of masitinib in combination with FOLFIRI ( irinotecan, 5-fluorouracil and folinic acid) to placebo in combination with FOLFIRI in second line treatment of patients.

DISEASE(S): Metastatic Colorectal Cancer,Metastatic Colorectal Cancer After 1 Previous Line Of Treatment,Μεταστατικός Καρκίνος Παχέος Εντέρου Μετά Από 1 Προηγούμενη Γραμμή Θεραπείας,Colorectal Neoplasms

PROVIDER: 2202343 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR